Olympus Corp. of the Americas defeated a bid to reinstate a suit alleging the company violated the False Claims Act’s anti-retaliation provision by firing an executive who complained about alleged medical device fraud, in a ruling that addressed two matters of first impression for the Third Circuit.
A federal district court correctly found that Paul Lisenby, the former global head of product development, failed to properly allege he engaged in protected activity under the FCA, Chief Judge Michael A. Chagares of the US Court of Appeals for the Third Circuit said in an opinion Tuesday.
In a matter of first ...
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Log in to keep reading or access research tools and resources.
In a contentious interview on CNN’s “State of the Union,” Health and Human Services Secretary Robert F. Kennedy Jr. made several false, misleading and baseless claims about the origins of Lyme dise...